Compositions and methods for treating cancer
US8329665B2 · kind B2 · utility
5Cited by
26References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2010 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | May 12, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.